Amyloidosis (Light Chain): Organs Affected, Symptoms, Treatments
Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study - The Lancet Haematology
Amyloid Goiter as the First Recognizable Manifestation of Immunoglobulin Light Chain Amyloidosis - AACE Clinical Case Reports
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment - Gertz - 2020 - American Journal of Hematology - Wiley Online Library
What do I need to know about immunoglobulin light chain (AL) amyloidosis? - ScienceDirect
Light-Chain (AL) Amyloidosis: Diagnosis and Treatment | American Society of Nephrology
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis - ScienceDirect
How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis) - Clinical Lymphoma, Myeloma and Leukemia
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
PLOS ONE: Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease - Kidney International Reports
Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease - Kidney International Reports
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response | Heart
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing) DOI:10.1039/C8CC04396E
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
Cardiac amyloidosis: An update on diagnosis and treatment | Cleveland Clinic Journal of Medicine
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
PLOS ONE: Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing)
Therapies for cardiac light chain amyloidosis: An update - International Journal of Cardiology
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment - Gertz - 2018 - American Journal of Hematology - Wiley Online Library
Amyloidosis (Light Chain): Organs Affected, Symptoms, Treatments
Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate* - Journal of Biological Chemistry
